Hepatitis C Market Overview (2026–2030): Industry Developments and Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Hepatitis C Market From 2026 To 2030?

The hepatitis c market has experienced rapid growth in recent years. It is anticipated to increase from $75.72 billion in 2025 to $86.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.5%. This historical expansion can be attributed to improvements in blood screening practices, the broader availability of antiviral drugs, a rise in diagnosis rates, heightened awareness of viral hepatitis, and support from public health initiatives.

The hepatitis c market is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $153.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. The projected growth during this period stems from factors such as heightened elimination goals set by health bodies, increased funding for hepatitis screening, wider implementation of streamlined treatment approaches, the spread of telemedicine-supported care, and improved accessibility in developing regions. Key trends anticipated during the forecast period involve a greater uptake of direct-acting antivirals, an intensified emphasis on early screening initiatives, broadened availability of curative therapeutic regimens, the proliferation of public health awareness efforts, and a stronger commitment to ensuring treatment adherence.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Primary Drivers Are Impacting The Hepatitis C Market Growth?

The hepatitis C market is anticipated to expand due to an expected rise in viral infections. Viral infections are defined as illnesses in the body caused by a virus. Hepatitis C treatment works to reduce viral load by eradicating the infection and restoring the immune response in patients after viral clearance. For example, data from August 2024 by the Centers for Disease Control and Prevention, a US-based public health agency, indicated an increase in the percentage of individuals affected by Parvovirus B19, a seasonal respiratory viral infection, across all age groups. This percentage rose from 3% between 2022 and 2024 to 10% in June 2024, with children aged 5–9 years experiencing the most significant surge, as their prevalence jumped from 15% in 2022–2024 to 40% by June 2024. Moreover, the proportion of pooled samples containing parvovirus B19 DNA levels saw a substantial increase from 1.5% in December 2023 to 19.9% in June 2024. This increasing incidence of viral infections is therefore a key driver for the hepatitis C market.

Which Segment Classifications Are Used In The Hepatitis C Market Segment Analysis?

The hepatitis c market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

Which Trends Are Shaping Growth In The Hepatitis C Market?

Leading companies within the hepatitis C market are concentrating on developing sophisticated products, such as combined antigen and antibody diagnostic tests, to enhance the accuracy and efficiency of early diagnosis and treatment. A combined antigen and antibody diagnostic test identifies both the presence of hepatitis C virus (HCV) antigens and antibodies in a patient’s blood. For instance, in July 2023, Roche Diagnostics, a Switzerland-based company that develops diagnostic tests, instruments, and digital solutions, launched Elecsys HCV Duo in India. Elecsys HCV Duo is a dual antigen and antibody diagnostic test created for the simultaneous detection of both the hepatitis C virus (HCV) antigen and antibodies from a single plasma or serum sample. The test’s dual detection capability addresses the challenge of asymptomatic early infections, which often go undiagnosed due to the absence of antibodies in the initial stages. By identifying active infections sooner, the Elecsys HCV Duo helps healthcare providers initiate appropriate treatment plans more quickly, potentially reducing disease progression and transmission rates.

Which Firms Are Contributing To The Hepatitis C Market Ecosystem?

Major companies operating in the hepatitis c market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Get The Full Hepatitis C Market Report:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Where Is The Hepatitis C Market Most Concentrated Geographically?

North America was the largest region in the hepatitis C market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hepatitis C Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Browse Through More Reports Similar to the Global Hepatitis C Market 2026, By The Business Research Company

Hepatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Preventive Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795